Marathon CEO tries to call a time out on con­tro­ver­sy as law­mak­ers rip in­to $89K de­flaza­cort price

Sen­a­tor Bernie Sanders and Con­gress­man Eli­jah Cum­mings have found their new poster boy for phar­ma price goug­ing. His name is Jeff Aronin, the CEO of Marathon Phar­ma­ceu­ti­cals.

In a joint let­ter ad­dressed to Aronin, the two law­mak­ers slammed the com­pa­ny’s “out­ra­geous plans” to set a list price of $89,000 on their new­ly ap­proved de­flaza­cort, a cheap steroid that’s been avail­able for decades in oth­er coun­tries around the world. And they launched an in­ves­ti­ga­tion in­to Marathon’s plans, de­mand­ing doc­u­ments re­lat­ed to the ac­tu­al cost of the pro­gram while in­sist­ing that Marathon “sig­nif­i­cant­ly low­er the price” for re­leas­ing the drug.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER